Formalin-Fixed
Paraffin-Embedded
(FFPE) Tissue

Accelerate your oncology, immunology, and other disease area programs with the largest, most extensively characterized FFPE inventory, fortified by rigorous quality assurance through triple pathologist-review of hyper-annotated® FFPE blocks, curls, and slides.

Access to FFPE tissue should be as diverse as the disease itself.

Discovery Life Sciences takes a Science at Your Service™ approach to provide scientists worldwide with a diverse range of highly characterized (hyper annotated®) human FFPE biospecimens to accelerate all your programs.

RELIABLE FFPE SELECTION WITH DIGITAL H&E SLIDES

ACTIONABLE SAMPLE DATA

SAMPLE INTEGRITY

QUICK SAMPLE DELIVERY

SORTABLE INVENTORY REPORT

UNMATCHED ACCESS

Featured FFPE Products

STAND-ALONE FFPE

3x pathologist-reviewed FFPE tissue with 40x digital H&E scans available from over 30,000 cases.

FFPE + Matched DTCs

Discovery’s quality FFPE tissue matched with dissociated tumor cells with cell count and HLA-typing

SpecimenSeq™ FFPE

NGS-characterized FFPE tissue. >40,000+ detections of 500+ specific genes across 19 oncology indications and 900+ unique patients.

FFPE + Matched Flash Frozen Tissue

Mirrored pairs of consented flash frozen tissue and FFPE. More than 175mg of flash frozen tissue & full FFPE blocks.

SpecimenSeq™ FFPE + Matched Plasma

1,200+ detections of 54 clinically relevant genes across 30 oncology indications and 200+ unique patients.

FFPE + Matched Plasma + Buffy Coat

Quality Discovery Life Sciences FFPE with matched plasma (Streck and K2EDTA available) and buffy coat.

AI-Annotated FFPE Tissues with Precise Tumor Content Quantification

Discovery has deployed PathAI’s AISight® workflow solutions in our pathology workflow, enabling a new level of precision in tumor content quantification.  AI-annotation is able to calculate tumor percent at a decimal-point level of precision, surpassing the traditional qualitative assessments of pathologists and empowering faster turnaround times for large-scale research projects.

ArtifactDetect automatically identifies potential histology and scanning QC issues.
TumorDetect identifies and quantifies cancer area, cancer stroma, and necrosis.

AISight® is for Research Use Only in the US; AISight® Dx is CE-IVD marked in the EEA, UK, and Switzerland. ArtifactDetect and TumorDetect are research use only products available on AISight® Image Management System, not for use in diagnostic procedures.

Get More from Your FFPE Tissue

Discovery’s proprietary dual nucleic acid extraction enables reliable, reproducible low-input RNA-Seq

FFPE Technical Resources

White Paper

Optimized Methods For Sequencing RNA From FFPE Samples White Papers

Webinar

ASHG 2019 Presentation Webinars & Videos

Poster

AACR 2023 - Characterization of a Novel Immunohistochemistry (IHC) Assay for CEACAM5 Using a Commercial Antibody Abstracts & Posters

Need molecular characterization for your FFPE tissue?

While our biospecimens are highly characterized, we also provide streamlined multi-omic analyses to further characterize biospecimens from our inventory or from your studies via our global CLIA / CAP service laboratories.*

DISCOVERY GENOMICS

MOLECULAR PATHOLOGY

*Not all service laboratories have CLIA certification or CAP accreditation. Inquire to learn more.

Get Help Finding the Right FFPE Product

Expertise across different molecular pathology platforms in CLIA-certified, CAP-accredited, and GCLP-compliant laboratories.

Contact Us Today

Quick Links

Technologies

Development and Clinical
Trial Solutions

Privacy Settings